Correlation Between Aerovate Therapeutics and Tombstone Exploration

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Tombstone Exploration at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Tombstone Exploration into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Tombstone Exploration Corp, you can compare the effects of market volatilities on Aerovate Therapeutics and Tombstone Exploration and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Tombstone Exploration. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Tombstone Exploration.

Diversification Opportunities for Aerovate Therapeutics and Tombstone Exploration

-0.64
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Aerovate and Tombstone is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Tombstone Exploration Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tombstone Exploration and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Tombstone Exploration. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tombstone Exploration has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Tombstone Exploration go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Tombstone Exploration

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the Tombstone Exploration. But the stock apears to be less risky and, when comparing its historical volatility, Aerovate Therapeutics is 18.11 times less risky than Tombstone Exploration. The stock trades about 0.0 of its potential returns per unit of risk. The Tombstone Exploration Corp is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  40.00  in Tombstone Exploration Corp on September 14, 2024 and sell it today you would lose (39.99) from holding Tombstone Exploration Corp or give up 99.97% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.8%
ValuesDaily Returns

Aerovate Therapeutics  vs.  Tombstone Exploration Corp

 Performance 
       Timeline  
Aerovate Therapeutics 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Tombstone Exploration 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tombstone Exploration Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Aerovate Therapeutics and Tombstone Exploration Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aerovate Therapeutics and Tombstone Exploration

The main advantage of trading using opposite Aerovate Therapeutics and Tombstone Exploration positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Tombstone Exploration can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tombstone Exploration will offset losses from the drop in Tombstone Exploration's long position.
The idea behind Aerovate Therapeutics and Tombstone Exploration Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories